Top compounds associated with response to TRIM16L


Feature Type Standardized
Nominal ANOVA
mRNA alisertib:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.0035 0.9
mRNA BIBR-1532 CTRPv2 pan-cancer AAC 0.0037 0.9
mRNA bafilomycin A1 CTRPv2 pan-cancer AAC -0.013 0.9
mRNA Platin CTRPv2 pan-cancer AAC 0.0033 0.9
mRNA Gefitinib CTRPv2 pan-cancer AAC 0.0032 0.9
mRNA BRD-K27188169:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.0046 0.9
mRNA cabozantinib CTRPv2 pan-cancer AAC -0.0031 0.9
mRNA istradefylline CTRPv2 pan-cancer AAC -0.0047 0.9
mRNA BMS-536924 CTRPv2 pan-cancer AAC 0.003 0.9
mRNA BRD-K71781559 CTRPv2 pan-cancer AAC -0.003 0.9
Download CSV